Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J9ZF
|
||||
Former ID |
DNC013019
|
||||
Drug Name |
4-benzyl-2-methylphthalazin-1(2H)-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H14N2O
|
||||
Canonical SMILES |
CN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=CC=C3
|
||||
InChI |
1S/C16H14N2O/c1-18-16(19)14-10-6-5-9-13(14)15(17-18)11-12-7-3-2-4-8-12/h2-10H,11H2,1H3
|
||||
InChIKey |
KUTSOIMAOFABLX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-1D adrenergic receptor | Target Info | Inhibitor | [1] | |
Alpha-1A adrenergic receptor | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Calcium signaling pathway | ||||
cGMP-PKG signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Adrenergic signaling in cardiomyocytes | |||||
Vascular smooth muscle contraction | |||||
Salivary secretionhsa04020:Calcium signaling pathway | |||||
AMPK signaling pathway | |||||
Salivary secretion | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
Reactome | Adrenoceptors | ||||
G alpha (q) signalling events | |||||
G alpha (12/13) signalling eventsR-HSA-390696:Adrenoceptors | |||||
G alpha (12/13) signalling events | |||||
WikiPathways | Monoamine GPCRs | ||||
Calcium Regulation in the Cardiac Cell | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP58:Monoamine GPCRs | |||||
Endothelin Pathways | |||||
AMPK Signaling | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2006 May 15;16(10):2786-90. Epub 2006 Mar 2.Vasorelaxant activity of phthalazinones and related compounds. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.